BioForm Medical, Inc. to Launch New 1.5cc RADIESSE(r) Volume Advantage Syringe and 0.8cc RADIESSE Moderate Fill Syringe; Announces Successful Results of RADIESSE Dermal Filler With Lidocaine Clinical Study

SAN MATEO, Calif., March 6, 2009 (GLOBE NEWSWIRE) -- BioForm Medical, Inc. (Nasdaq:BFRM) today announced two new product forms of RADIESSE(r) dermal filler - the 1.5cc RADIESSE Volume Advantage syringe and the 0.8cc RADIESSE Moderate Fill syringe - which will be introduced at the American Academy of Dermatology's (AAD) 67th Annual Meeting in San Francisco, California. These product introductions are intended to provide physicians with greater value and versatility.